Skip to main content
SAREUM HOLDINGS PLC logo

SAREUM HOLDINGS PLC — Investor Relations & Filings

Ticker · SAR ISIN · GB00BMC3RJ87 LEI · 213800PKERN2DY8FFM72 IL Manufacturing
Open in API
Filings indexed 348 across all filing types
Latest filing 2022-02-14 Regulatory Filings
Country GB United Kingdom
Listing IL SAR

About SAREUM HOLDINGS PLC

https://www.sareum.com/

Sareum Holdings PLC is a clinical-stage small molecule company that discovers and develops next-generation kinase inhibitors for the treatment of autoimmune diseases and cancer. The company's research is primarily focused on the TYK/JAK kinase cell signalling family, with a specific emphasis on developing dual inhibitors of TYK2 and JAK1. This approach is pursued for its potential to offer superior efficacy compared to agents that target only one of these kinases. Its development pipeline includes SDC-1801, a potential oral therapy for autoimmune diseases, as well as other programs targeting cancer and viral infections.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1937 chars) and contains an RNS Number (6253B) and mentions RNS, the news service of the London Stock Exchange, which is approved by the Financial Conduct Authority (FCA). The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement made via the regulatory news service. Since this is a general regulatory announcement that doesn't fit the specific categories like DIV, DIRS, or ER, and it is an announcement rather than a full report, the most appropriate classification is the general regulatory filing category, RNS.
2022-02-14 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and contains information related to the London Stock Exchange's trading mechanisms ('Price Monitoring Extension', 'auction call period'). It concludes by stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates that the document is a general regulatory announcement disseminated through the RNS system, which aligns with the 'Regulatory Filings' category (RNS) as a miscellaneous regulatory update that doesn't fit the more specific categories like 10-K, ER, or DIV. The length is short, suggesting it is an announcement rather than a comprehensive report.
2022-02-14 English
Publication of Circular; Notice of General Meeting
Regulatory Filings Classification · 98% confidence The document is titled "Publication of Circular and Notice of General Meeting" and announces the publication of a Circular and a Notice for an Extraordinary General Meeting (EGM). It details proposed actions (share consolidation and adoption of new articles of association) that require shareholder approval at this meeting. The document is distributed via RNS (Regulatory News Service) and contains an expected timetable leading up to the General Meeting. Since the core purpose is announcing the availability of a Circular and Notice for a shareholder meeting, it strongly relates to proxy solicitation and information provided to shareholders ahead of a vote. However, the document itself is an announcement about the publication of these materials, not the materials themselves (like the proxy statement or the AGM presentation). Given the content focuses on calling a General Meeting and providing details about the proposed resolutions, it aligns closely with the scope of materials related to shareholder meetings. The most specific category for materials soliciting shareholder votes and providing meeting information is PSI (Proxy Solicitation & Information Statement). Although it is an announcement of publication, the content is the substance of the meeting materials. If it were purely a short announcement stating 'the proxy statement is attached,' RPA might apply, but this document details the corporate actions being proposed for the meeting. Since it is a formal announcement regarding the meeting and the associated documents (Circular/Notice), and the Circular contains the details shareholders need to vote, PSI is the best fit for the underlying subject matter, even if it's delivered via an RNS announcement format. The presence of the RNS header and the nature of the announcement suggest it is a regulatory filing, but PSI is more specific to the content type (meeting notice/circular). I will classify it as PSI because the content is the core information for the upcoming shareholder vote.
2022-02-04 English
Correction - Issue of Warrants
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content details the 'Issue of Warrants - Correction made to expiry of subscription date,' which is a specific corporate action announcement related to capital structure and financing instruments (warrants). This type of announcement, especially when distributed via RNS, fits best under the general 'Regulatory Filings' category (RNS) as it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change (MANG). Although it relates to capital, it is a notification of an issuance/correction rather than a broad financing update (CAP) or share repurchase (POS). Given the source (RNS) and the nature of the announcement (a correction to a previous issuance detail), RNS is the most appropriate classification.
2022-01-28 English
Issue of Warrants
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content announces the 'Issue of Warrants' as consideration for services, which is a specific corporate action related to capital structure and financing. This type of announcement, distributed via the RNS system, is a general regulatory announcement. Since the specific action (issuance of warrants/options) is not explicitly covered by codes like SHA (Share Issue/Capital Change, which usually implies primary issuance or splits) or CAP (Capital/Financing Update, which is broader), and given its nature as a formal, brief regulatory news service release, the most appropriate general category for a non-standard, mandatory disclosure via RNS is the Regulatory Filings fallback code.
2022-01-28 English
Sareum to Participate in Edison Open House Event
Regulatory Filings Classification · 100% confidence The document is a formal announcement disseminated via the RNS system (indicated by 'RNS Number : 4453Z' and the footer mentioning 'Reach, the non-regulatory press release distribution service of RNS'). The content announces Sareum's participation in the Edison Group's Global Healthcare 'Open House' Virtual Conference and mentions that the CEO will discuss company progress. Crucially, it states, 'No material new information will be made available.' This structure—a brief announcement about participation in an event where only previously disclosed information will be discussed—is characteristic of a general corporate update or regulatory filing that doesn't fit a specific financial report category. Since it is a general announcement distributed through the RNS/Reach service and does not fit into specific categories like ER, IR, 10-K, or DIV, the most appropriate fallback category is Regulatory Filings (RNS). The document length (5780 chars) is substantial enough that it's not just a placeholder, but its content is purely informational about an event, not a core financial disclosure.
2022-01-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.